Navigating the Controversies and Complexities of Implementing Lecanemab in the Veterans Affairs Health System.

The article focuses on the evolving landscape of Alzheimer's disease (AD) diagnosis and treatment, particularly the implementation of anti-amyloid therapies like lecanemab within the Veterans Health Administration (VHA). It highlights the shift from clinical diagnosis to biomarker-based confirmation...

Descripción completa

Detalles Bibliográficos

Publicado en:	Journal of the American Geriatrics Society Vol. 73; no. 10; pp. 2983 - 2986
Autores principales:	Yang, Mia, Chodosh, Joshua
Formato:	Artículo
Publicado:	Wiley-Blackwell Oct2025
Materias:	United States. Dept. of Veterans Affairs Human services programs Conflict (Psychology) Cost benefit analysis Therapeutic use of monoclonal antibodies Alzheimer's disease Medical care of veterans Surveys Conceptual structures Amyloid beta-protein precursor Chemical inhibitors
Acceso en línea:	Ver este registro en EBSCOhost